Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Tatsuki R Kataoka

15PUBLICATIONS

69CO-AUTHORS

Predictive and prognostic markersObstetrics and gynaecologyCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityTumour immunology

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (15)

Sort by Publication Date:

|Apr 16, 2026

Dynamic changes in serum HER2-peptide-specific autoantibodies predict response to neoadjuvant therapy in HER2-positive breast cancer.

|Sep 18, 2025

Aberrant Expression of Gonadotropin-Releasing Hormone Receptor in Human Mast Cells Enhances the Recruitments of Trophoblasts and NK Cells.

Takashi Matsuzaki, Hiroaki Hamaguchi, Ken R Ito

|May 20, 2024

Long-term outcomes of neoadjuvant trastuzumab emtansine + pertuzumab (T-DM1 + P) and docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP) for HER2-positive primary breast cancer: results of the randomized phase 2 JBCRG20 study (Neo-peaks).

Toshimi Takano, Norikazu Masuda, Mitsuya Ito

|Feb 24, 2024

A Novel Hemocyte-Derived Peptide and Its Possible Roles in Immune Response of <i>Ciona intestinalis</i> Type A.

Shin Matsubara, Rin Iguchi, Michio Ogasawara

|Jan 17, 2024

Image-based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast Cancer.

Chowdhury Arif Jahangir, David B Page, Glenn Broeckx

|Aug 23, 2023

Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer

Jeppe Thagaard, Glenn Broeckx, David B Page

Pageof 3

Frequent Collaborators

3 joint publications

David B Page

3 joint publications

Anita Grigoriadis

3 joint publications

Jorge S Reis-Filho

3 joint publications

Steven N Hart

3 joint publications

Flavio Luis Dantas Portela

3 joint publications

Rajarsi R Gupta

3 joint publications

Chowdhury Arif Jahangir

3 joint publications

Alexandros Hardas

3 joint publications

Tilman T Rau

3 joint publications

Paula I Gonzalez-Ericsson

Frequent Collaborators

3 joint publications

David B Page

3 joint publications

Anita Grigoriadis

3 joint publications

Jorge S Reis-Filho

3 joint publications

Steven N Hart

Top Related Videos

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on : May 09, 2025

Isolation of Leukocytes from the Human Maternal-fetal Interface

Isolation of Leukocytes from the Human Maternal-fetal Interface

Published on : May 21, 2015

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

See more related videos

Top Related Videos

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on : May 09, 2025

Isolation of Leukocytes from the Human Maternal-fetal Interface

Isolation of Leukocytes from the Human Maternal-fetal Interface

Published on : May 21, 2015

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

See more related videos